Literature DB >> 25480562

IFN-γ regulates CD8+ memory T cell differentiation and survival in response to weak, but not strong, TCR signals.

Diana Stoycheva1, Katrin Deiser1, Lilian Stärck2, Gopala Nishanth3, Dirk Schlüter3, Wolfgang Uckert4, Thomas Schüler5.   

Abstract

In response to primary Ag contact, naive mouse CD8(+) T cells undergo clonal expansion and differentiate into effector T cells. After pathogen clearance, most effector T cells die, and only a small number of memory T cell precursors (TMPs) survive to form a pool of long-lived memory T cells (TMs). Although high- and low-affinity CD8(+) T cell clones are recruited into the primary response, the TM pool consists mainly of high-affinity clones. It remains unclear whether the more efficient expansion of high-affinity clones and/or cell-intrinsic processes exclude low-affinity T cells from the TM pool. In this article, we show that the lack of IFN-γR signaling in CD8(+) T cells promotes TM formation in response to weak, but not strong, TCR agonists. The IFN-γ-sensitive accumulation of TMs correlates with reduced mammalian target of rapamycin activation and the accumulation of long-lived CD62L(hi)Bcl-2(hi)Eomes(hi) TMPs. Reconstitution of mammalian target of rapamycin or IFN-γR signaling is sufficient to block this process. Hence, our data suggest that IFN-γR signaling actively blocks the formation of TMPs responding to weak TCR agonists, thereby promoting the accumulation of high-affinity T cells finally dominating the TM pool.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480562     DOI: 10.4049/jimmunol.1402058

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.

Authors:  David Merino; David San Segundo; Juan M Medina; Emilio Rodrigo; Esther Asensio; Juan Irure; Gema Fernández-Fresnedo; Manuel A Arias; Marcos López-Hoyos
Journal:  Immunology       Date:  2016-03-29       Impact factor: 7.397

2.  Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.

Authors:  Timothy J Vreeland; Jennifer K Litton; Na Qiao; Anne V Philips; Gheath Alatrash; Diane F Hale; Doreen O Jackson; Kaitlin M Peace; Julia M Greene; John S Berry; Guy T Clifton; George E Peoples; Elizabeth A Mittendorf
Journal:  Clin Immunol       Date:  2018-03-21       Impact factor: 3.969

3.  Localization of the T-cell response to RSV infection is altered in infant mice.

Authors:  Katherine M Eichinger; Jessica L Kosanovich; Kerry M Empey
Journal:  Pediatr Pulmonol       Date:  2017-11-08

4.  Immune Autoregulatory CD8 T Cells Require IFN-γ Responsiveness to Optimally Suppress Central Nervous System Autoimmunity.

Authors:  Alexander W Boyden; Ashley A Brate; Laura M Stephens; Nitin J Karandikar
Journal:  J Immunol       Date:  2020-06-12       Impact factor: 5.422

Review 5.  mTOR Regulation of Lymphoid Cells in Immunity to Pathogens.

Authors:  Rachael Keating; Maureen Ann McGargill
Journal:  Front Immunol       Date:  2016-05-11       Impact factor: 7.561

6.  mTOR Modulates Lymphocyte Differentiation through T-bet and Eomesodermin in Response to Invasive Pulmonary Aspergillosis in Rats.

Authors:  Na Cui; Long-Xiang Su; Hao Wang; Meng Xiao; Fei Yang; Min Zheng; Xin Li; Ying-Chun Xu; Da-Wei Liu
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

7.  Interaction effects among IFN-γ+874, IL-2-330, IL-10-1082, IL-10-592 and IL-4-589 polymorphisms on the clinical progression of subjects infected with hepatitis B virus and/or hepatitis C virus: a retrospective nested case-control study.

Authors:  Qiu-Ju Gao; Jia-Xin Xie; Li-Min Wang; Qiang Zhou; Shi-Yong Zhang
Journal:  BMJ Open       Date:  2017-08-23       Impact factor: 2.692

8.  Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development.

Authors:  J S Berry; T J Vreeland; D F Hale; D O Jackson; A F Trappey; J M Greene; M O Hardin; G S Herbert; G T Clifton; G E Peoples
Journal:  J Cancer       Date:  2017-05-11       Impact factor: 4.207

Review 9.  Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors:  Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Nat Rev Immunol       Date:  2021-06-21       Impact factor: 53.106

10.  Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host Cells.

Authors:  Katrin Deiser; Diana Stoycheva; Ute Bank; Thomas Blankenstein; Thomas Schüler
Journal:  PLoS One       Date:  2016-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.